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Abstract
Twin registries around the globe have collected DNA samples from large numbers of monozygotic and dizygotic
twins. The twin sample collections are frequently used as controls in disease-specific studies together with non-twins.
This approach is unbiased under the hypothesis that twins and singletons are comparable in terms of allele
frequencies; i.e. there are no genetic variants associated with being a twin per se. To test this hypothesis we
performed a genome-wide association study comparing the allele frequency of 572,352 single nucleotide
polymorphisms (SNPs) in 1,413 monozygotic (MZ) and 5,451 dizygotic (DZ) twins with 3,720 healthy singletons.
Twins and singletons have been genotyped using the same platform. SNPs showing association with being a twin at
P-value < 1 × 10-5 were selected for replication analysis in 1,492 twins (463 MZ and 1,029 DZ) and 1,880 singletons
from Finland. No SNPs reached genome-wide significance (P-value < 5 × 10-8) in the main analysis combining MZ
and DZ twins. In a secondary analysis including only DZ twins two SNPs (rs2033541 close to ADAMTSL1 and
rs4149283 close to ABCA1) were genome-wide significant after meta-analysis with the Finnish population. The
estimated proportion of variance on the liability scale explained by all SNPs was 0.08 (P-value=0.003) when MZ and
DZ were considered together and smaller for MZ (0.06, P-value=0.10) compared to DZ (0.09, P-value=0.003) when
analyzed separately. In conclusion, twins and singletons can be used in genetic studies together with general
population samples without introducing large bias. Further research is needed to explore genetic variances
associated with DZ twinning.
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Introduction
Twin brothers and sisters have been extensively studied in
Genetic Epidemiology with the aim of disentangling the genetic
architecture of multiple biological and behavioral traits.
Traditionally, this has been done by mean of quantitative
genetic modeling, in which observed and expected variance/
covariance structures are estimated and compared utilizing
phenotypic twin data [1].
The possibility of using these twin data for such scientific
purposes has driven the establishment of multiple large twin
cohort studies and registries around the globe [2,3].
These registries have traditionally focused on collecting
phenotypic data longitudinally on large numbers of participants.
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However, because of the recent advances in genotyping
methods, many twin registries collect DNA from the
participating twins. Given the population based nature of most
twin cohorts, analyzing this genomic material would allow
studying not only the genetic architecture of the collected
phenotypes, but also the identical by descent (IBD) sharing of
alleles [4], MZ discordant pair analyses [5], gene-environment
interactions [6] or joint linkage and association analysis [7]. In
addition, the unselected nature of twin participants makes them
attractive to be used as controls in disease-specific studies
from the same background populations. Nevertheless, in order
to develop these approaches in an unbiased manner, twins
need to be comparable to singletons in other aspects than the
investigated disease. One concern could be that twins have
lower birth-weight than singletons [8], mainly due to reduced
growth during the third trimester [9]. Low birth-weight has been
associated with increased risk of cardiovascular diseases,
diabetes and a number of other diseases [10]. Nevertheless
health outcomes associated with low birth-weight have been
shown to be generally very similar between twins and
singletons [11] [12] [13]. A more direct concern for the reliability
of the results from genetic association studies using twins as
controls is that the genetic architecture of twins and non-twins
is comparable and that there are no specific variants
associated with being a twin. Previous studies have suggested
the existence of a genetic contribution to DZ twinning [14] [15].
However, candidate-gene studies have failed to identify any
genetic variance associated with DZ twinning in families [16]
[17]. The genetic contribution to MZ twinning has been
debated, and although it is generally accepted to be a
spontaneous event, uninfluenced by genetic factor, maternal
age, parity or race, some studies have suggested that a
propensity to MZ twinning can be inherited through the
maternal line [18].
We first performed a genome-wide association (GWA) study
comparing twins participating in the TwinGene study with
healthy singletons enrolled as controls in a large study on
schizophrenia susceptibility. Second, we attempted to replicate
SNPs showing association with being a twin at P-value < 1 ×
10-5 in a sample of twins and singletons from Finland.
Since most twin studies jointly used MZ and DZ in GWAS,
we focused on this combined outcome in our primary analysis.
In secondary analysis DZ twins were studied separately. This
stratified analysis was justified by two reasons. First, some twin
materials may consist of purely MZ or DZ twins and second, if
genetic variants predisposing to multiple ovulations exist, their
detection would be improved by including only DZ twins given
the differences in the biological origins of MZ and DZ twins
[19].
Methods
Study sample
TwinGene.  The Swedish Twin Registry is a population-
based national register currently including close to 200,000
Swedish twins born from 1886 to 2008 [20]. TwinGene is a
sub-study that has been conducted within The Swedish Twin
Registry to examine associations between genetic factors and
common complex disease. Twins born before 1958 were
contacted to participate between April 2004 and December
2008. Health and medication data were collected from self-
report questionnaires and blood sampling material was mailed
to the subject who then contacted a local health care center for
blood sampling and a health check-up. In the present analysis
we include all the individuals whose co-twin did not participate
and randomly selected one individual from each twin pair in
which both members participated. This was done to address
our research objectives without the added complexity of
modeling familial clustering. In total, N=6,886 twins were
included in the current study. All the participants in the
TwinGene study gave written informed consent and the Ethics
Committee of Karolinska Institutet approved the study.
Population Controls.  The controls from a large study on
schizophrenia susceptibility were used as comparison non-twin
“control” material [21]. The schizophrenia study was conducted
concomitantly with TwinGene and at the same department
(Medical Epidemiology and Biostatistics, Karolinska Institutet).
The same procedures for collection of blood, extraction of DNA
and storage were implemented by the same biobank (KI
Biobank) as for TwinGene. The schizophrenia study consists of
11,244 individuals (5,001 cases and 6,243 controls) collected
during 6 study waves. The controls had to be born in Sweden
or another Nordic country and were identified from national
population registers and frequency matched to cases by age,
gender and county of residence. Controls had never received a
discharge diagnosis of schizophrenia or bipolar disorder. To
avoid potential bias introduced from considering schizophrenic
patients, we only included the schizophrenia control subjects
as controls in our study. Furthermore, due to heterogeneity in
genotyping platforms, we only included the fifth and sixth wave
of the Swedish schizophrenia study, which used the same
platforms as TwinGene (Illumina OmniExpress), giving a total
of N=3,729 singleton controls. All the participants in this study
gave written informed consent and the Ethics Committee of
Karolinska Institutet approved the study.
The Finnish twin cohort.  Part of the replication analyses
utilized data from the FinnTwin12 (FT12) and FinnTwin16
(FT16) cohort studies. Briefly, both the FT12 and FT16 are
population based-cohort longitudinal studies including five
consecutive birth cohorts of Finnish twins born between 1983
and 1987 (FT12) and between 1975 and 1979 (FT16). Initially,
all twins and their parents were approached by letter and
invited to participate in the autumn of the year in which their
birth cohort reached 11 years of age (FT12), or in the 1-2
months following the twins’ 16th birthday (FT16). The response
rate in both the FT12 and FT16 was very high at all times
(>85%). After giving written informed consent, participants from
both cohorts were surveyed at the baseline and the
subsequent follow-ups concerning their health habits and
attitudes, symptom checklists, personality scales and social
relationships. Furthermore, all twins donated blood samples
during a visit to the twin research clinic in Helsinki, Finland at
the last follow-up (young adulthood) for genetic and
biochemistry analyses. These biological samples were stored
subsequently at the National Institute for Health and Welfare
inside freezers at -80°C. Data collection and analysis were
Genetic of Twins and Singletons
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approved by the ethics committees of the Department of Public
Health of the University of Helsinki, the Helsinki and Uusimaa
Hospital District and the IRB of Indiana University. Similar to
what done in TwinGene, only one individual from each twin pair
was included in the present analysis.
Predict-CVD.  The Predict-CVD sample (used here as
Finnish controls) belongs to the larger FINRISK study. In brief,
FINRISK is a cross-sectional population surveys originally
created to investigate incident cardiovascular diseases within
Finnish population by collecting information on relevant chronic
diseases (e.g. CVD, diabetes, obesity, cancer) and health
related behaviors in the adult population. The survey has been
carried out every 5 years since 1972. DNA samples were
collected in the following survey years: 1987, 1992, 1997,
2002, 2007, and 2012. A more detailed description of the
FINRISK study can be found elsewhere [22].
The Predict-CVD sub-cohort is a random subset of the whole
FINRISK cohort, and as such, representative of the full study
population. The participants of the Predict-CVD were selected
using random sampling stratified by sex and cohort (i.e.
FINRISK 1992, 1997, 2002 or 2007 cohorts), so that each sub-
cohort member had a sex/cohort specific equal sampling
weight [23]. The size of sub-cohort in each stratum was made
proportional to the number of incident cardiovascular disease
cases in the corresponding stratum.
Genotyping
TwinGene and the Swedish schizophrenia study were
genotyped with Illumina HumanOmniExpress (≈730,000
SNPs). TwinGene genotyping was performed at the Uppsala
University SNP Technology Platform (www.genotyping.se).
Schizophrenia control samples were genotyped by the Genetic
Analysis Platform at The Broad Institute of Harvard and MIT.
Both facilities followed standard protocols and use same
genotype calling (GenomeStudio). All Finnish twins and
controls were genotyped using the Illumina 670K custom chip
at the Welcome Trust Sanger Centre.
Statistical Analysis
TwinGene and Schizophrenia controls used study-specific
quality control criteria. In order to harmonize the data we
performed an additional quality control after merging the
genotype data from the two studies. Specifically, SNPs which
were not present in both studies were removed, SNPs with call
rate <97%, minor allele frequency <1% or Hardy Weinberg
equilibrium exact test P-value < 1x10-7 were also removed.
Moreover, we excluded individuals with missing genotype data
> 3% and we corrected for deviating heterozygosity excluding
individuals with an F inbreeding coefficient calculated using
PLINK [24] larger than 5 standard deviations from the sample
mean. To account for population stratification we adjusted our
analysis for 3 multidimensional scaling coefficients (MSCs).
More than 100,000 SNPs were removed because of SNP
call-rate < 97%. This is expected when two non-imputed
datasets, which have already been processed with separate
quality controls, are combined. In particular, all those SNPs
that were present in only one of the two studies were excluded.
After quality control, 572,352 SNPs and 10,584 individuals
(6,864 twins and 3,720 controls) were included in stage 1
analysis. For each SNP we performed an additive logistic
model for association with being a twin (MZ and DZ together or
DZ separately) adjusting for birth year, sex and MSC.
We performed in silico replication analysis in 3,372 Finnish
individuals (1,492 twins and 1,880 controls) for SNPs showing
association with being a twin in stage 1 analysis at P-value < 1
× 10-5. Replications samples followed similar quality control and
merging procedures used in the Swedish samples. Logistic
regression adjusting for birth year, sex and MSC was used to
estimate the association between the SNPs selected in stage 1
and being a twin. Results form stage 1 and 2 were meta-
analyzed using a random effects model based on inverse-
variance-weighting.
Population stratification was monitored by inspecting the
three first 3 MSCs in the Finnish and Swedish sample (Figure
S1). Lack of population stratification is further supported by the
low inflation factor λ=1.03 observed in the GWAS performed in
stage 1.
To perform power calculations we used the CaTs calculator
[25] with a genome-wide significance P-value threshold of 5 ×
10-8.
We estimated the proportion of variance explained by
common SNPs in our genotyping array using the Genome-wide
Complex Trait Analysis (GCTA) software [26]. It has been
shown that a stringent quality control is needed to increase the
quality of the estimations [27] and therefore we have restricted
the analysis on SNPs with minor allele frequency > 0.05 and
excluded individuals with a pairwise pedigree relationship >
0.025. To transform the estimate of the heritability from the
observed to the liability scale we assumed a prevalence of DZ
and MZ of 2.8% and 1.1%, respectively.
Results
Main characteristics of our populations are described in
Table 1. In the Swedish samples, twins were older than
controls but with similar sex distribution; approximately 80% of
the twins were DZ. In the Finnish samples twins were in
average 22 years younger than controls. In Table 2 we report
the loci associated with being a twin (MZ+DZ) at P-value < 1 ×
10-5 in stage 1. No SNP displayed genome-wide significant
association (P-value < 5 × 10-8) with being a twin. The lowest
P-values were observed for rs2033541 close to ADAMTSL1,
rs1554783 close to SYNE1 and rs4149283 close to ABCA1,
None of these SNPs showed genome-wide significant
association in meta-analysis with the Finnish samples (Table
2).
We performed a secondary GWA analysis with the same set
of controls but this time including only DZ twins as cases.
Results are shown in Table 3. When DZ twins were considered
alone, rs2033541 close to ADAMTSL1 and rs4149283 close to
ABCA1 reached genome-wide significance (Figures S2 and
S3). The same direction of association was observed in the
Finnish samples, albeit the association was not significant at a
nominal P-value of 0.05. However, when meta-analyzed, the
two SNPs reached genome-wide significant association
Genetic of Twins and Singletons
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(rs2033541: OR=0.84, P-value=5 × 10-9; rs4149283: OR=0.64,
P-value=4 × 10-8).
No genome-wide significant associations were observed
when MZ were considered alone, neither in stage 1 nor in
meta-analysis (Table 4).
To investigate what effect-size we had power to detect in the
current setting we performed a power calculation [25]. The
prevalence of twins in the investigated age-group is close to
2%. With such prevalence and assumption of allele frequency
of 0.5 we had, in the stage 1 analysis, 76% and 95% power to
detect odds ratios of 1.21 and 1.25, respectively. The same OR
would have been detected with a power of 48% and 80%
considering an allele frequency of 0.2.
We estimated that the proportion of phenotypic variance on
liability scale explained by all common SNPs available in our
genotyping array (“chip heritability”) was 0.06 [standard error
(s.e.): 0.05, P-value=0.10] in MZ and 0.09 (s.e: 0.03, P-
value=0.003) in DZ twins. When MZ and DZ twins were
analyzed together, the estimated proportion was 0.08 (s.e:
0.03, P-value=0.003).
Discussion
We conducted this analysis to test the hypothesis that twins
have similar genetic architecture as singletons. If this is the
case, biological twinness does not confound GWAS, and as
consequence, genetic data derived from twins can be used in
such studies without introducing large bias. On the other hand,
if genetic variants associated with biological twinness exist,
they can bias GWAS in two ways. First, if the twins are used as
healthy controls in disease-specific GWAS, spurious
association can be detected. Second, if the GWAS is
conducted only on twins or in combined samples where twins
and non-twins are analyzed together (for example to
investigate a continuous phenotype) spurious association can
be detected if the genetic variants associated with biological
twinness are also associated with the phenotype of interest.
Table 1. Baseline Characteristics.
 Stage 1
Stage 2 - in silico
replication
 
TwinGene -
Cases
(N=6864)
ISC -
Controls
(N=3720)
Finnish
Twins -
Cases
(N=1492)
PreCVD -
Controls
(N=1880)
Sex - No. (%)     
 Male 3275 (48) 1919 (52) 841 (56) 1189 (63)
 Female 3589 (52) 1801 (48) 653 (44) 691 (37)
Average birth year - yr.
(sd) 1941 (8.9)
1952
(10.9) 1967 (18) 1945 (13)
Zygosity - No (%)     
 Monozygotic 1413 (21) - 463 (31) -
 Dizygotic 5451 (79) - 1029 (69) -
doi: 10.1371/journal.pone.0083101.t001
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In the present study we did not find common genetic variants
that were associated with being a twin. In a secondary analysis
of DZ twins versus non-twins, we identified two SNPs that were
genome-wide significant in the stage 1 and when meta-
analysed with the Finnish samples. Given our sample size, we
have 80% power to detect genetic variants with an effect size
of 1.22 and 1.25 and an allele frequency of 0.50 and 0.20,
respectively. Therefore, rarer variants or variants with smaller
effect size might have been missed in this study. To evaluate
the potential for discovery of SNPs associated with twinness,
we estimated the proportion of variance on liability scale
explained by all common SNPs available in our genotyping
array. A high proportion of variance would indicate that
common SNPs play a large role and thus, that many
associated SNPs might be discovered with larger samples. We
observed a small proportion of variance explained (0.06 for MZ
and 0.09 for DZ twins) indicating that there is, relatively
speaking, a limited potential for discovery of many genetic
variants associated with biological twinness
Twins samples have already been used in several GWA
studies, together with other singletons samples or
independently. A genotyped sample of individuals from the UK
twin registry has been part of a large number of GWA meta-
analysis [28]. In 2010, more than 30 GWA meta-analyses have
been published using these data (http://www.twinsuk.ac.uk/
publications.html#2010). GWA studies have also been
performed only using samples of related individuals. For
example, a GWAS for association with height and body mass
index has been conducted in a sub-sample of the Australian
Twin Registry including 11,536 individuals composed of
Australian twins, family members, and unrelated individuals
[29]. The authors reported a single genome- wide significant
variant for height with an effect size that was comparable with
that observed in a previous GWA study of unrelated individuals
[30]. Genome-wide association meta-analysis consortia
conventionally perform quality controls to identify heterogeneity
among studies. It might be argued that, if twins were
genetically different from singletons, this would already have
been picked up and reported by such consortia. This is
however true only if a large part of the genetic associations in a
specific study differ from those detected in the other studies
(e.g. due to population stratification). Instead, it would not be
reported if a few variants, for example those that hypothetically
might be associated with being a twin, were heterogeneous
across studies. The only exception would be when these
variants also happened to be the top-findings of the disease
investigated by the GWAS. This study is, to our knowledge, the
first genome-wide investigation comparing genetic variants in
twins and singletons from the same underlying population. An
important strength is that the samples were handled and
extracted by the same biobank and genotyped with identical
platforms, minimizing potential biases due to technical
differences between platforms and providing the advantage of
not having to rely on imputation.
Although practically identical procedures and platforms were
used, the twins and singletons were genotyped in different
laboratories and at different time-points. This might have
introduced systematic bias by increasing the risk to detect
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spurious association and by inflating the estimates of the
proportion of variance explained by all common SNPs.
However, these are issues only if positive findings are
observed. Because our main analysis on twins compared to
non-twins revealed no significant locus and the estimated
“chip-heritability” was low, we consider the effect of this
potential bias negligible.
It is important to highlight that the aim of this study was not to
identify new genetic variants predisposing to twinning, for
example, by influencing the probability of blastocyst
fragmentation, multiple ovulation or mere survival of more than
one concomitant fetus. We recognize that to pursue this aim a
better approach would be to investigate the genetic
architecture of parents of MZ and DZ twins. Other studies with
larger sample size are needed to investigate these hypotheses.
Nevertheless, we identified two loci, ADAMTSL1 and ABCB1,
likely to be associated with DZ twinness. ABCA1 is involved in
cholesterol transport and SNP markers on the same loci have
been found previously associated with HDL-levels in several
large GWAS [31-33]. Further research is needed to confirm
these findings and elucidate the potential role of these loci in
relation to factors predisposing to DZ twinning.
We used a Finnish population to replicate SNPs with a p-
value < 1 × 10-5 in the main analysis. Finns are considered an
outlier population on the European genetic landscape [34],
other populations such as Danes or Germans could be argued
to be more suitable to replicate findings from Swedish
individuals. However, genetic data from Finnish population,
including twins from the Finnish Twin Cohort, have been used
in a large number of GWA studies (http://www.euengage.org/
press.html) and results have been reasonably comparable to
those observed in other European populations. In addition, it
should be acknowledged that, while we know that both Predict-
CVD study sample and the wave 5 and 6 of the Swedish
schizophrenia study do not include pairs of relatives, it is
uncertain whether any of the participants to these studies could
be a member of a twin pair. Notwithstanding, while this may
potentially introduce an error in our analyses, it may be safely
neglected as twins would represent ~2% of the participants in
these population-based samples.
In conclusion, we did not find evidence for large genetic
differences between twins and singletons, supporting the
practice to use twins together with singletons in genetic studies
without introducing bias.
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